Effect of clofibrate in jaundiced term newborns

Indian Journal of Pediatrics

Volumn 72, Issue 2, 2005, Pages 123-126

  Mohammadzadeh, A ^a   Farhat, A Sh ^a   Iranpour, R ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clofibrate; Hyperbilirubinemia; Jaundice; Neonate

Indexed keywords

BILIRUBIN; CLOFIBRATE; ENZYME INDUCING AGENT; GLUCURONOSYLTRANSFERASE; MESOPORPHYRIN TIN; METALLOPORPHYRIN;

ADVERSE DRUG REACTION; ARTICLE; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG APPROVAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERBILIRUBINEMIA; IRAN; MALE; NEWBORN JAUNDICE; PHOTOTHERAPY;

EID: 15044352782     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02760695     Document Type: Article

References (14)

1. Newman TB, Maisels MS. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995; 96: 730-733
2. American Academy of Pediatrics. Practice parameter: management of Hyperbilirubinemia in the healthy term newborn. Provisional Committee for Quality Improvement and Subcommittee on hyperbilirubinemia. Pediatrics 1994; 94: 558-565.
3. Maisels MJ. Neonatal Hyperbilirubinemia. In Klaus MH, Fanaroff AA, eds. Care of the High-Risk Neonate. Pennsylvania: Saunders, 2001: 324-362.
4. Jahnson LH, Brown AK, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of Kernicterus. J Pediatr 2002; 140: 397-386.
5. Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol 2002; 7(2): 111-119.
6. Brun S, Carmona MC, Mampel T, Vinas O, Giralt M, Iglesias R, et al. Activators of peroxisome proliferator-acrivated receptor-alpha induce the expression of the uncoupling pritein-3 gene expression at birth. Diabetes 1999; 48(6): 1217-2122.
7. Kutz K, Kandler H, Gugler R, Fevery J. Effect of clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilbert's syndrome. Clin Sci 1984; 66(4): 389-397.
8. Lindenbaum A, Delaporte B, Benattar C, Dehan M, Magny JF, Gerbet D et al. Preventive treatment of jaundice in Preterm newborn infants with clofibrate. Double blind controlled therapeutic trial. Arch Fr Pediatr 1985; 42(9): 759-63. French
9. Bourget P, Broise I, Quinquis-Desmaris V, Gabilan JC. Pharmacokinetics of clofibrate in jaundiced newborn infants at term. Arch Perdiatr 1995; 2(8): 722-728.
10. Gabilan JC. Pharmacologic treatment of neonatal jaundice. A new approach. Arch Pediatr 1998; 5(11): 1274-1278.
11. Hansen TW, Tommarello S. Effect of phenobarbital on bilirubin metabolism in rat brain. Biol Neonate 1998; 73(2): 106-111.
12. Lindenbaum A, Hernandorena X, Vial M, Benattar C, Janaud JC, Dehan M et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study. Arch Fr Pediatr 1981; 38 Suppl 1: 867-73.
13. Steiner A, Weisser B, Vetter N. A comparative review of the advers effects of treatments for huperbilirubinemia. Drug Saf 1991; 6(2): 118-130.
14. Bhutani VK, Johnson LH. Newborn Jaundice and Kernicterus-Health and Societal Perspectives. Indian J Pediatr 2003; 70(5): 407-416.